MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Vues
• 07/02/23
0
0
Intégrer
administrator
Les abonnés
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires